Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus.

Katsuno, Tomoyuki; Ikeda, Hiroki; Namba, Mitsuyoshi

Katsuno, Tomoyuki; Ikeda, Hiroki; Namba, Mitsuyoshi.

Afiliação

Katsuno T; Division of Innovative Diabetes Treatment, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan. katsunoa@hyo-med.ac.jp.
Ikeda H; Ikeda Hospital, 1-18-5 Tsukaguchi-cho, Amagasaki, Hyogo, 661-0002, Japan.
Namba M; Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.

Diabetes Ther ; 7(2): 309-20, 2016 Jun.

Article em En | MEDLINE | ID: mdl-27114254

Palavras-chave

Dipeptidyl peptidase-4 inhibitor; Hemoglobin A1c; Insulin therapy; Type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Diabetes Ther Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google